Jnana Therapeutics

Jnana Therapeutics

  • Founded: 2016
  • Location: Boston, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1b
  • Therapy area: Phenylketonuria
  • Drug types: GEN, NPH, RAR, PED, IMM, ONC, NEU
  • Lead product: JNT-517
  • Product link: https://www.jnanatx.com/programs/
  • Funding: $107M C Nov 2022; $50M B Aug 2021; $50M A Dec 2017
  • Investors: Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures



job board

Short description:

SLC transporter Drug Discovery

Drug notes:

5+ additional undisclosed programs RD immune-mediated & inflammatory diseases, oncology, neurology

Long description:

Jnana Therapeutics specializes in discovering and developing medicines to expand the universe of therapeutic impact. By combining deep drug discovery, development expertise and their proprietary technology, Jnana is unlocking highly validated but previously undruggable targets. Drug discovery involves use of Jnana’s chemoproteomic platform, Reactive Affinity Probe Interaction Discovery (RAPID), a proprietary ligand platform to identify small molecule binders irrespective of the target. The unbiased approach of RAPID allows challenging targets, such as transcription factors and helicases, to be investigated. By using their RAPID platform, Jnana is developing a pipeline targeting many rare genetic diseases, immune-mediated diseases and oncology.


Jnana Therapeutics
In Vivo Biologist
Boston, MA|30 days ago
Jnana Therapeutics
Don't see a perfect job? Apply opportunistically.
Boston, MA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com